EA
DPLO

Emerald Acquisition’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Emerald Acquisition’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.97M Buy
177,275
+60,921
+52% +$2.04M 0.01% 1222
2016
Q2 		$4.07M Buy
+116,354
New +$3.66M 0.01% 1461

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Emerald Acquisition's DPLO Position: Q3 2016 in Review

Emerald Acquisition increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 52% in Q3 2016, buying an estimated $2.04M and bringing the position to 177,275 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #1222.

Emerald Acquisition first reported a position in DPLO in Q2 2016 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold DPLO as of Q3 2016.

  • Emerald Acquisition held 177,275 shares of DIPLOMAT PHARMACY, INC. worth $4.97M as of Q3 2016.
  • Emerald Acquisition bought 60,921 DIPLOMAT PHARMACY, INC. shares in Q3 2016, an estimated $2.04M.
  • DIPLOMAT PHARMACY, INC. made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1222 holding.
  • Emerald Acquisition first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and has held it in 2 quarters since.
  • 185 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.